CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR)

CUSIP: 17331Y109

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common stock, $0.0001 par value
Shares outstanding
80,864,905
Total 13F shares
8,357,159
Share change
+8,129,667
Total reported value
$16,966,429
Price per share
$2.03
Number of holders
16
Value change
+$16,255,712
Number of buys
13
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 17331Y109?
CUSIP 17331Y109 identifies CTOR - CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR) as of Q3 2025

As of 30 Sep 2025, CITIUS ONCOLOGY, INC. - Common stock, $0.0001 par value (CTOR) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,357,159 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, IFP Advisors, Inc, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, and Tower Research Capital LLC (TRC). This page lists 16 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.